Impact of 5-HTTLPR and BDNF polymorphisms on response to sertraline versus transcranial direct current stimulation: Implications for the serotonergic system

European Neuropsychopharmacology

Volumn 23, Issue 11, 2013, Pages 1530-1540

  Brunoni, A R ^a,b   Kemp, A H ^c   Shiozawa, P ^b   Cordeiro, Q ^b   Valiengo, L C L ^a   Goulart, A C ^a   Coprerski, B ^d   Lotufo, P A ^a   Brunoni, D ^d   Perez, A B A ^d   Fregni, F ^e   Bensenor I M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FACULDADE DE CIÊNCIAS MÉDICAS DA SANTA CASA DE SÃO PAULO   (Brazil)

^c UNIVERSITY OF SYDNEY   (Australia)

^d FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^e and Red Sox Foundation and Massachusetts General Hospital Home Base Program   (United States)

Author keywords

Brain derived neurotrophic factor polymorphism; Major depressive disorder; Serotonin selective reuptake blockers; Serotonin transporter linked polymorphic region; Single nucleotide polymorphism; Transcranial direct current stimulation

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; PLACEBO; SEROTONIN RECEPTOR; SERTRALINE;

ADULT; ALLELE; AMYGDALOID NUCLEUS; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PREDICTOR VARIABLE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEROTONINERGIC SYSTEM; TRANSCRANIAL DIRECT CURRENT STIMULATION; TREATMENT RESPONSE;

BRAIN-DERIVED NEUROTROPHIC FACTOR POLYMORPHISM; MAJOR DEPRESSIVE DISORDER; SEROTONIN SELECTIVE REUPTAKE BLOCKERS; SEROTONIN-TRANSPORTER-LINKED-POLYMORPHIC REGION; SINGLE-NUCLEOTIDE POLYMORPHISM; TRANSCRANIAL DIRECT CURRENT STIMULATION;

ADOLESCENT; ADULT; AGED; ALLELES; BRAIN-DERIVED NEUROTROPHIC FACTOR; COMBINED MODALITY THERAPY; DEPRESSIVE DISORDER, MAJOR; DOUBLE-BLIND METHOD; ELECTRIC STIMULATION THERAPY; EPISTASIS, GENETIC; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SEROTONERGIC NEURONS; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SERTRALINE; TREATMENT OUTCOME;

EID: 84886795638     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2013.03.009     Document Type: Article

References (57)

1. Amorim P. Mini International Neuropsychiatric Interview (MINI): validation of a short structured diagnostic psychiatric interview. Rev. Bras. Psiquiatr. 2000, 22:106-115.
2. Baeken C., De Raedt R., Bossuyt A., Van Hove C., Mertens J., Dobbeleir A., Blanckaert P., Goethals I. The impact of HF-rTMS treatment on serotonin(2A) receptors in unipolar melancholic depression. Brain Stimulation 2011, 4:104-111.
3. Bocchio-Chiavetto L., Bagnardi V., Zanardini R., Molteni R., Nielsen M.G., Placentino A., Giovannini C., Rillosi L., Ventriglia M., Riva M.A., Gennarelli M. Serum and plasma BDNF levels in major depression: a replication study and meta-analyses. World J. Biol. Psychiatry 2010, 11:763-773.
4. Bocchio-Chiavetto L., Miniussi C., Zanardini R., Gazzoli A., Bignotti S., Specchia C., Gennarelli M. 5-HTTLPR and BDNF Val66Met polymorphisms and response to rTMS treatment in drug resistant depression. Neurosci. Lett. 2008, 437:130-134.
5. Boggio P.S., Rigonatti S.P., Ribeiro R.B., Myczkowski M.L., Nitsche M.A., Pascual-Leone A., Fregni F. A randomized, double-blind clinical trial on the efficacy of cortical direct current stimulation for the treatment of major depression. Int. J. Neuropsychopharmacol. 2008, 11:249-254.
6. Brunoni A.R., Amadera J., Berbel B., Volz M.S., Rizzerio B.G., Fregni F. A systematic review on reporting and assessment of adverse effects associated with transcranial direct current stimulation. Int. J. Neuropsychopharmacol. 2011, 14:1133-1145.
7. Brunoni A.R., Lopes M., Fregni F. A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression. Int. J. Neuropsychopharmacol. 2008, 11:1169-1180.
8. Brunoni A.R., Valiengo L., Baccaro A., Zanao T.A., de Oliveira J.F., Vieira G.P., Bueno V.F., Goulart A.C., Boggio P.S., Lotufo P.A., Bensenor I.M., Fregni F. Sertraline vs. ELectrical Current Therapy for Treating Depression Clinical Trial-SELECT TDCS: design, rationale and objectives. Contemp. Clin. Trials 2011, 32:90-98.
9. Brunoni, A.R., Valiengo, L., Baccaro, A., Zanao, T.A., Oliveira, A.C., Goulart, A.C., Boggio, P.S., Lotufo, P.A., Bensenor, I.J., Fregni, F., 2013a. The sertraline versus electrical current therapy for treating depression clinical study: results from a factorial, randomized, controlled trial. JAMA Psychiatry [Epub ahead of print].
10. Brunoni A.R., Vanderhasselt M.A., Boggio P.S., Fregni F., Dantas E.M., Mill J.G., Lotufo P.A., Bensenor I.J. Polarity- and valence-dependent effects of prefrontal transcranial direct current stimulation on heart rate variability and salivary cortisol. Psychoneuroendocrinology 2013, 38:58-66.
11. Cohen J. Statistical Power Analysis for the Behavioral Sciences 1988, Lawrence Erlbaum Associates, Inc., New Jersey. 2nd ed.
12. Collier D.A., Stober G., Li T., Heils A., Catalano M., Di Bella D., Arranz M.J., Murray R.M., Vallada H.P., Bengel D., Muller C.R., Roberts G.W., Smeraldi E., Kirov G., Sham P., Lesch K.P. A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders. Molecular Psychiatry 1996, 1:453-460.
13. Cordeiro Q., Souza B.R., Correa H., Guindalini C., Hutz M.H., Vallada H., Romano-Silva M.A. A review of psychiatric genetics research in the Brazilian population. Rev. Bras. Psiquiatr. 2009, 31:154-162.
14. D'Haenen H., Bossuyt A., Mertens J., Bossuyt-Piron C., Gijsemans M., Kaufman L. SPECT imaging of serotonin2 receptors in depression. Psychiatry Res. 1992, 45:227-237.
15. Dell'osso B., Zanoni S., Ferrucci R., Vergari M., Castellano F., D'Urso N., Dobrea C., Benatti B., Arici C., Priori A., Altamura A.C. Transcranial direct current stimulation for the outpatient treatment of poor-responder depressed patients. Eur. Psychiatry: J. Assoc. Eur. Psychiatrists 2012, 27:513-517.
16. Domschke K., Lawford B., Laje G., Berger K., Young R., Morris P., Deckert J., Arolt V., McMahon F.J., Baune B.T. Brain-derived neurotrophic factor ( BDNF) gene: no major impact on antidepressant treatment response. Int. J. Neuropsychopharmacol. 2010, 13:93-101.
17. Drevets W.C., Price J.L., Furey M.L. Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Brain Struct. Funct. 2008, 213:93-118.
18. Egan M.F., Kojima M., Callicott J.H., Goldberg T.E., Kolachana B.S., Bertolino A., Zaitsev E., Gold B., Goldman D., Dean M., Lu B., Weinberger D.R. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003, 112:257-269.
19. Ferrucci R., Bortolomasi M., Vergari M., Tadini L., Salvoro B., Giacopuzzi M., Barbieri S., Priori A. Transcranial direct current stimulation in severe, drug-resistant major depression. J. Affect Disord. 2009, 118:215-219.
20. Fritsch B., Reis J., Martinowich K., Schambra H.M., Ji Y., Cohen L.G., Lu B. Direct current stimulation promotes BDNF-dependent synaptic plasticity: potential implications for motor learning. Neuron 2010, 66:198-204.
21. Gelenberg A.J., Thase M.E., Meyer R.E., Goodwin F.K., Katz M.M., Kraemer H.C., Potter W.Z., Shelton R.C., Fava M., Khan A., Trivedi M.H., Ninan P.T., Mann J.J., Bergeson S., Endicott J., Kocsis J.H., Leon A.C., Manji H.K., Rosenbaum J.F. The history and current state of antidepressant clinical trial design: a call to action for proof-of-concept studies. J. Clin. Psychiatry 2008, 69:1513-1528.
22. George M.S., Lisanby S.H., Avery D., McDonald W.M., Durkalski V., Pavlicova M., Anderson B., Nahas Z., Bulow P., Zarkowski P., Holtzheimer P.E., Schwartz T., Sackeim H.A. Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial. Arch. Gen. Psychiatry 2010, 67:507-516.
23. Hariri A.R., Drabant E.M., Munoz K.E., Kolachana B.S., Mattay V.S., Egan M.F., Weinberger D.R. A susceptibility gene for affective disorders and the response of the human amygdala. Arch. Gen. Psychiatry 2005, 62:146-152.
24. Hariri A.R., Holmes A. Genetics of emotional regulation: the role of the serotonin transporter in neural function. Trends Cognitive Sci. 2006, 10:182-191.
25. Heils A., Teufel A., Petri S., Stober G., Riederer P., Bengel D., Lesch K.P. Allelic variation of human serotonin transporter gene expression. J. Neurochem. 1996, 66:2621-2624.
26. Hu X.Z., Lipsky R.H., Zhu G., Akhtar L.A., Taubman J., Greenberg B.D., Xu K., Arnold P.D., Richter M.A., Kennedy J.L., Murphy D.L., Goldman D. Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. Am. J. Hum. Genet. 2006, 78:815-826.
27. Hu X.Z., Rush A.J., Charney D., Wilson A.F., Sorant A.J., Papanicolaou G.J., Fava M., Trivedi M.H., Wisniewski S.R., Laje G., Paddock S., McMahon F.J., Manji H., Lipsky R.H. Association between a functional serotonin transporter promoter polymorphism and citalopram treatment in adult outpatients with major depression. Arch. Gen. Psychiatry 2007, 64:783-792.
28. Kalu U.G., Sexton C.E., Loo C.K., Ebmeier K.P. Transcranial direct current stimulation in the treatment of major depression: a meta-analysis. Psychol. Med. 2012, 42:1791-1800.
29. Kemp A.H., Gordon E., Rush A.J., Williams L.M. Improving the prediction of treatment response in depression: integration of clinical, cognitive, psychophysiological, neuroimaging, and genetic measures. CNS Spectrums 2008, 13:1066-1086. quiz 1087-1068.
30. Klein, M., Camardo, J., Kandel, E.R., 1982. Serotonin modulates a specific potassium current in the sensory neurons that show presynaptic facilitation in Aplysia. Proc. Natl. Acad. Sci. USA 79, 5713-5717.
31. Kraft J.B., Peters E.J., Slager S.L., Jenkins G.D., Reinalda M.S., McGrath P.J., Hamilton S.P. Analysis of association between the serotonin transporter and antidepressant response in a large clinical sample. Biol. Psychiatry 2007, 61:734-742.
32. Leonard B.E., Myint A. The psychoneuroimmunology of depression. Hum. Psychopharmacol. 2009, 24:165-175.
33. Levine J., Schooler N.R. SAFTEE: a technique for the systematic assessment of side effects in clinical trials. Psychopharmacol. Bull. 1986, 22:343-381.
34. Loo C.K., Alonzo A., Martin D., Mitchell P.B., Galvez V., Sachdev P. Transcranial direct current stimulation for depression: 3-week, randomised, sham-controlled trial. Br. J. Psychiatry 2012, 200:52-59.
35. Loo C.K., Sachdev P., Martin D., Pigot M., Alonzo A., Malhi G.S., Lagopoulos J., Mitchell P. A double-blind, sham-controlled trial of transcranial direct current stimulation for the treatment of depression. Int. J. Neuropsychopharmacol. 2010, 13:61-69.
36. Malaguti A., Rossini D., Lucca A., Magri L., Lorenzi C., Pirovano A., Colombo C., Smeraldi E., Zanardi R. Role of COMT, 5-HT(1A), and SERT genetic polymorphisms on antidepressant response to Transcranial Magnetic Stimulation. Depress. Anxiety 2011, 28:568-573.
37. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988, 16:1215.
38. Mrazek D.A., Rush A.J., Biernacka J.M., O'Kane D.J., Cunningham J.M., Wieben E.D., Schaid D.J., Drews M.S., Courson V.L., Snyder K.A., Black J.L., Weinshilboum R.M. SLC6A4 variation and citalopram response. Am. J. Med. Genet. B Neuropsychiatric Genet.: Off. Publ. Int. Soc. Psychiatric Genet. 2009, 150B:341-351.
39. Nitsche M.A., Jaussi W., Liebetanz D., Lang N., Tergau F., Paulus W. Consolidation of human motor cortical neuroplasticity by d-cycloserine. Neuropsychopharmacology 2004, 29:1573-1578.
40. Nitsche M.A., Kuo M.F., Karrasch R., Wachter B., Liebetanz D., Paulus W. Serotonin affects transcranial direct current-induced neuroplasticity in humans. Biol. Psychiatry 2009, 66:503-508.
41. Nitsche M.A., Liebetanz D., Antal A., Lang N., Tergau F., Paulus W. Modulation of cortical excitability by weak direct current stimulation-technical, safety and functional aspects. Suppl. Clin. Neurophysiol. 2003, 56:255-276.
42. Nitsche M.A., Paulus W. Excitability changes induced in the human motor cortex by weak transcranial direct current stimulation. J. Physiol. 2000, 527(Pt 3):633-639.
43. O'Reardon J.P., Cristancho P., Pilania P., Bapatla K.B., Chuai S., Peshek A.D. Patients with a major depressive episode responding to treatment with repetitive transcranial magnetic stimulation (rTMS) are resistant to the effects of rapid tryptophan depletion. Depress. Anxiety 2007, 24:537-544.
44. Ott J. Methods of analysis and resources available for genetic trait mapping. J. Hered. 1999, 90:68-70.
45. Palm U., Schiller C., Fintescu Z., Obermeier M., Keeser D., Reisinger E., Pogarell O., Nitsche M.A., Moller H.J., Padberg F. Transcranial direct current stimulation in treatment resistant depression: a randomized double-blind, placebo-controlled study. Brain Stimulation 2012, 5:242-251.
46. Parra F.C., Amado R.C., Lambertucci J.R., Rocha J., Antunes C.M., Pena S.D. Color and genomic ancestry in Brazilians. Proc. Natl. Acad. Sci. USA 2003, 100:177-182.
47. Pattwell S.S., Bath K.G., Perez-Castro R., Lee F.S., Chao M.V., Ninan I. The BDNF Val66Met polymorphism impairs synaptic transmission and plasticity in the infralimbic medial prefrontal cortex. J. Neurosci.: Off. J. Soc. Neurosci. 2012, 32:2410-2421.
48. Porcelli S., Fabbri C., Serretti A. Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with antidepressant efficacy. Eur. Neuropsychopharmacol.: J. Eur. Coll. Neuropsychopharmacol. 2012, 22:239-258.
49. Sen S., Duman R., Sanacora G. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol. Psychiatry 2008, 64:527-532.
50. Serretti A., Kato M., De Ronchi D., Kinoshita T. Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients. Mol. Psychiatry 2007, 12:247-257.
51. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., Hergueta T., Baker R., Dunbar G.C. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry 1998, 59(Suppl. 20):22-33. quiz 34-57.
52. Stagg C.J., Nitsche M.A. Physiological basis of transcranial direct current stimulation. Neuroscientist 2011, 17:37-53.
53. Taylor M.J., Sen S., Bhagwagar Z. Antidepressant response and the serotonin transporter gene-linked polymorphic region. Biol. Psychiatry 2010, 68:536-543.
54. Twisk J., Proper K. Evaluation of the results of a randomized controlled trial: how to define changes between baseline and follow-up. J. Clin. Epidemiol. 2004, 57:223-228.
55. Weiss S.T., Silverman E.K., Palmer L.J. Case-control association studies in pharmacogenetics. Pharmacogenomics J. 2001, 1:157-158.
56. Zanardi R., Magri L., Rossini D., Malaguti A., Giordani S., Lorenzi C., Pirovano A., Smeraldi E., Lucca A. Role of serotonergic gene polymorphisms on response to transcranial magnetic stimulation in depression. Eur. Neuropsychopharmacol.: J. Eur. Coll. Neuropsychopharmacol. 2007, 17:651-657.
57. Zou Y.F., Ye D.Q., Feng X.L., Su H., Pan F.M., Liao F.F. Meta-analysis of BDNF Val66Met polymorphism association with treatment response in patients with major depressive disorder. Eur. Neuropsychopharmacol. 2010, 20:535-544.